With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...

On January 28, 2025, the Company received clearance of its IND from the FDA to initiate a first-in-human Phase 1 dose ...

A Durham company is pushing back on media reports questioning the safety of its lead product as the firm begins its commercial launch.

Learn more about whether Alvotech or Vericel Corporation is a better investment based on AAII's A+ Investor grades, which ...

Live updates on stocks, bonds and markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Northwest Biotherapeutics Inc. can proceed with claims against seven firms including Citadel Securities, Susquehanna International Group, and Virtu Americas LLC for depressing the company’s stock ...

Beam Therapeutics BEAM has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives ...

Shanghai Henlius Biotech and Organon (OGN) announced that the European Medicines Agency has validated the marketing authorization application ...

Thrivent Financial for Lutherans reduced its stake in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 1.9% in the 4th quarter, ...

Research analysts at HC Wainwright dropped their FY2026 earnings per share (EPS) estimates for Unity Biotechnology in a ...

Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals ...